ARCHIVES

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

This article is from The Cancer Letter archive.

Vol. 39 No. 40 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

Program Project Guidelines Listed

March 18, 1977